Pharmaceuticals Companies By Shares Outstanding

Shares Outstanding
Shares OutstandingEfficiencyMarket RiskExp Return
1IDCN Indocan Resources
7.41 B
 0.00 
 0.00 
 0.00 
2PFE Pfizer Inc
5.69 B
 0.07 
 1.47 
 0.11 
3FITX Creative Edge Nutrit
4.75 B
 0.00 
 0.00 
 0.00 
4NVO Novo Nordisk AS
3.37 B
(0.11)
 3.85 
(0.44)
5TAK Takeda Pharmaceutical Co
3.16 B
 0.00 
 1.38 
 0.00 
6AZN AstraZeneca PLC ADR
3.1 B
 0.11 
 1.58 
 0.18 
7MRK Merck Company
2.51 B
 0.05 
 1.89 
 0.10 
8SNY Sanofi ADR
2.44 B
(0.03)
 1.78 
(0.05)
9JNJ Johnson Johnson
2.41 B
 0.14 
 1.31 
 0.18 
10BMY Bristol Myers Squibb
2.04 B
 0.00 
 1.92 
 0.00 
11GSK GlaxoSmithKline PLC ADR
2.02 B
 0.03 
 1.80 
 0.06 
12NVS Novartis AG ADR
1.94 B
 0.09 
 1.30 
 0.12 
13EAPH Easton Pharmaceutica
1.34 B
(0.13)
 12.80 
(1.64)
14VTRS Viatris
1.17 B
 0.01 
 1.97 
 0.02 
15TEVA Teva Pharma Industries
1.15 B
(0.08)
 2.43 
(0.20)
16TLRY Tilray Inc
1.1 B
 0.12 
 7.14 
 0.86 
17ADVT Advantis Corp
978.47 M
 0.00 
 0.00 
 0.00 
18LLY Eli Lilly and
897.74 M
 0.03 
 1.92 
 0.05 
19RDY Dr Reddys Laboratories
832.37 M
 0.05 
 1.49 
 0.08 
20INSD Instadose Pharma Corp
531.93 M
 0.00 
 0.00 
 0.00 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.